presented by Penn Medicine's Abramson Cancer Center
Thursday, June 20, 2019
5:30 – 9:15 PM
The Rittenhouse Hotel
210 W Rittenhouse Square
Philadelphia, PA 19103
This activity is designed to efficiently discuss the most recent clinical advances in oncology. The meeting will address the questions that have emerged from the latest data presented at major international annual meetings. Activity format will provide significant opportunity for interaction with Penn Medicine faculty and other attendees. Participants will leave with up-to-date, practical information with immediate clinical application, as well as a technical and scientific background on the current state of the field and emerging advances.
Who Should Attend
This activity has been designed for medical, surgical and radiation oncologists, hematologists/oncologists, hematology/oncology fellows, radiologists, urologists, gastroenterologists, dermatologists, pulmonologists, oncology nurses, and other healthcare professionals involved in the treatment of patients with cancer.
Upon completion of this course, participants should be able to:
- Identify recent advances in immunotherapy for cancer treatment
- Implement new clinical findings to a broad range of tumor types
- Identify issues related to extent of therapy by genomics, stage and patient condition
For additional information please contact Melissa Messinger.